RNS Number : 5247A
Northwest Biotherapeutics Inc
04 August 2008
|
For Immediate Release
|
August, 4 2008
|
Northwest Biotherapeutics
('NWBT' or the 'Company')
Director/PDMR Shareholding
Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO.US), announced that, on July 16, 2008, Toucan Partners LLC advised the Company that, on July 15, 2008, it had distributed 2,572,710 shares of Northwest's common stock to Linda F. Powers, Chairperson of Northwest's Board of Directors. Ms. Powers is a managing member and fifty percent owner of Toucan Partners, LLC.
As a result of this transfer, Ms. Powers now directly owns 2,572,710 shares representing 6.05%, and as managing member of Toucan Partners LLC and Toucan Capital Fund II, LP has an additional indirect interest in 45.42% of, Northwest's issued and outstanding stock.
After this transfer Toucan Partners, LLC owns no shares of NWBT but has a continuing interest in warrants to purchase 8,832,541 shares of the Company's common stock.
For further information, please contact:
|
Northwest Biotherapeutics
|
|
|
Anthony P. Deasey, Chief Financial Officer
|
+1 240-497-9024
|
|
|
|
|
Buchanan Communications
|
|
|
Lisa Baderoon (lisab@buchanan.uk.com) / Mary-Jane Johnson / Catherine Breen
|
+44 (0)20 7466 5000
|
|
|
|
|
Collins Stewart
|
|
|
Adam Cowen/Tim Mickley
|
+44 (0)20 7523 8230
|
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCPJMRTMMIMBJP